Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANTHONY J WEIDO

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1679570584
CMS profile
212068
Location
PASADENA, TX

General Payments · PY2018–2024

$52,427.28

  • Reported across 349 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$878.04

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $868.47 36
Consulting Fee $9.57 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,663.95 148
PY2019 $26,814.38 78
PY2020 $300.00 1
PY2021 $490.18 25
PY2022 $559.94 28
PY2023 $720.79 32
PY2024 $878.04 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADMA BioManufacturing LLC $9.57 06/10/2024 Consulting Fee Undisputed 01/23/2026 1149639464 CMS
AstraZeneca Pharmaceuticals LP $20.46 01/08/2024 Food and Beverage Undisputed 01/23/2026 1105522729 CMS
AstraZeneca Pharmaceuticals LP $17.32 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105404738 CMS
AstraZeneca Pharmaceuticals LP $46.79 02/13/2024 Food and Beverage Undisputed 01/23/2026 1105396990 CMS
AstraZeneca Pharmaceuticals LP $17.32 04/03/2024 Food and Beverage Undisputed 01/23/2026 1105870379 CMS
AstraZeneca Pharmaceuticals LP $16.98 11/05/2024 Food and Beverage Undisputed 01/23/2026 1104414053 CMS
AstraZeneca Pharmaceuticals LP $16.42 11/11/2024 Food and Beverage Undisputed 01/23/2026 1104457210 CMS
Blueprint Medicines Corporation $21.74 05/07/2024 Food and Beverage Undisputed 01/23/2026 1147444875 CMS
Blueprint Medicines Corporation $20.85 08/28/2024 Food and Beverage Undisputed 01/23/2026 1147444935 CMS
Blueprint Medicines Corporation $24.11 09/25/2024 Food and Beverage Undisputed 01/23/2026 1147444941 CMS
CSL Behring $19.49 02/29/2024 Food and Beverage Undisputed 01/23/2026 1134644127 CMS
CSL Behring $19.49 04/25/2024 Food and Beverage Undisputed 01/23/2026 1134644317 CMS
CSL Behring $21.60 09/19/2024 Food and Beverage Undisputed 01/23/2026 1134644335 CMS
Genentech USA, Inc. $113.75 08/08/2024 Food and Beverage Undisputed 01/23/2026 1132977947 CMS
GlaxoSmithKline, LLC. $18.44 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116690533 CMS
GlaxoSmithKline, LLC. $5.70 06/25/2024 Food and Beverage Undisputed 01/23/2026 1116236324 CMS
GlaxoSmithKline, LLC. $12.03 07/02/2024 Food and Beverage Undisputed 01/23/2026 1116513549 CMS
GlaxoSmithKline, LLC. $25.33 07/15/2024 Food and Beverage Undisputed 01/23/2026 1116491897 CMS
GlaxoSmithKline, LLC. $27.04 08/05/2024 Food and Beverage Undisputed 01/23/2026 1116545642 CMS
GlaxoSmithKline, LLC. $16.32 08/12/2024 Food and Beverage Undisputed 01/23/2026 1116518632 CMS
GlaxoSmithKline, LLC. $5.50 09/18/2024 Food and Beverage Undisputed 01/23/2026 1116060568 CMS
GlaxoSmithKline, LLC. $31.50 11/07/2024 Food and Beverage Undisputed 01/23/2026 1116359494 CMS
Hikma Pharmaceuticals USA $19.38 03/04/2024 Food and Beverage Undisputed 01/23/2026 1127506925 CMS
kaleo, Inc. $15.93 03/05/2024 Food and Beverage Undisputed 01/23/2026 1126622926 CMS
kaleo, Inc. $22.97 04/08/2024 Food and Beverage Undisputed 01/23/2026 1126622928 CMS
LEO Pharma Inc. $19.94 02/05/2024 Food and Beverage Undisputed 01/23/2026 1152655453 CMS
Novartis Pharmaceuticals Corporation $24.09 01/10/2024 Food and Beverage Undisputed 01/23/2026 1087426788 CMS
PFIZER INC. $15.45 06/05/2024 Food and Beverage Undisputed 01/23/2026 1131652431 CMS
Pharming Healthcare, Inc. $28.83 01/23/2024 Food and Beverage Undisputed 01/23/2026 1132170726 CMS
Pharming Healthcare, Inc. $18.55 10/24/2024 Food and Beverage Undisputed 01/23/2026 1132170734 CMS
Regeneron Healthcare Solutions, Inc. $18.88 07/12/2024 Food and Beverage Undisputed 01/23/2026 1114248787 CMS
Regeneron Healthcare Solutions, Inc. $23.95 10/11/2024 Food and Beverage Undisputed 01/23/2026 1114248790 CMS
Regeneron Healthcare Solutions, Inc. $17.08 11/18/2024 Food and Beverage Undisputed 01/23/2026 1114248795 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.30 02/27/2024 Food and Beverage Undisputed 01/23/2026 1137695766 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.97 03/05/2024 Food and Beverage Undisputed 01/23/2026 1137695768 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.46 03/08/2024 Food and Beverage Undisputed 01/23/2026 1137695770 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.51 07/16/2024 Food and Beverage Undisputed 01/23/2026 1137695772 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.